Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Mol Cancer. 2010 Jul 28;9:200. doi: 10.1186/1476-4598-9-200.
Heme Oxygenase-1 (HO-1) is expressed in many cancers and promotes growth and survival of neoplastic cells. Recently, HO-1 has been implicated in tumor cell invasion and metastasis. However, the molecular mechanisms underlying these biologic effects of HO-1 remain largely unknown. To identify a common mechanism of action of HO-1 in cancer, we determined the global effect of HO-1 on the transcriptome of multiple tumor entities and identified a universal HO-1-associated gene expression signature.
Genome-wide expression profiling of Heme Oxygenase-1 expressing versus HO-1 silenced BeWo choriocarcinoma cells as well as a comparative meta-profiling of the preexisting expression database of 190 human tumors of 14 independent cancer types led to the identification of 14 genes, the expression of which correlated strongly and universally with that of HO-1 (P = 0.00002). These genes included regulators of cell plasticity and extracellular matrix (ECM) remodeling (MMP2, ADAM8, TGFB1, BGN, COL21A1, PXDN), signaling (CRIP2, MICB), amino acid transport and glycosylation (SLC7A1 and ST3GAL2), estrogen and phospholipid biosynthesis (AGPAT2 and HSD17B1), protein stabilization (IFI30), and phosphorylation (ALPPL2). We selected PXDN, an adhesion molecule involved in ECM formation, for further analysis and functional characterization. Immunofluorescence and Western blotting confirmed the positive correlation of expression of PXDN and HO-1 in BeWo cancer cells as well as co-localization of these two proteins in invasive extravillous trophoblast cells. Modulation of HO-1 expression in both loss-of and gain-of function cell models (BeWo and 607B melanoma cells, respectively) demonstrated a direct relationship of HO-1 expression with cell adhesion to Fibronectin and Laminin coated wells. The adhesion-promoting effects of HO-1 were dependent on PXDN expression, as loss of PXDN in HO-1 expressing BeWo and 607B cells led to reduced cell attachment to Laminin and Fibronectin coated wells.
Collectively, our results show that HO-1 expression determines a distinct 'molecular signature' in cancer cells, which is enriched in genes associated with tumorigenesis. The protein network downstream of HO-1 modulates adhesion, signaling, transport, and other critical cellular functions of neoplastic cells and thus promotes tumor cell growth and dissemination.
血红素加氧酶-1(HO-1)在许多癌症中表达,并促进肿瘤细胞的生长和存活。最近,HO-1 已被牵连到肿瘤细胞的侵袭和转移中。然而,HO-1 这些生物学效应的分子机制在很大程度上仍然未知。为了确定 HO-1 在癌症中的共同作用机制,我们确定了 HO-1 对多种肿瘤实体转录组的全局影响,并鉴定了普遍存在的 HO-1 相关基因表达特征。
HO-1 表达的 BeWo 绒毛膜癌细胞与 HO-1 沉默的 BeWo 绒毛膜癌细胞的全基因组表达谱分析,以及对 14 种独立癌症类型的 190 个人类肿瘤的现有表达数据库的比较元分析,导致鉴定出 14 个基因,这些基因的表达与 HO-1 的表达强烈且普遍相关(P=0.00002)。这些基因包括细胞可塑性和细胞外基质(ECM)重塑的调节剂(MMP2、ADAM8、TGFB1、BGN、COL21A1、PXDN)、信号转导(CRIP2、MICB)、氨基酸转运和糖基化(SLC7A1 和 ST3GAL2)、雌激素和磷脂生物合成(AGPAT2 和 HSD17B1)、蛋白质稳定(IFI30)和磷酸化(ALPPL2)。我们选择参与 ECM 形成的黏附分子 PXDN 进行进一步分析和功能表征。免疫荧光和 Western blot 证实了 BeWo 癌细胞中 PXDN 和 HO-1 的表达呈正相关,以及这两种蛋白在侵袭性绒毛外滋养层细胞中的共定位。在 BeWo 和 607B 黑色素瘤细胞的失活和过表达功能模型中对 HO-1 表达的调节,证明了 HO-1 表达与细胞黏附到纤连蛋白和层粘连蛋白包被的孔直接相关。HO-1 的黏附促进作用依赖于 PXDN 的表达,因为在 HO-1 表达的 BeWo 和 607B 细胞中丧失 PXDN 会导致细胞黏附到纤连蛋白和层粘连蛋白包被的孔减少。
总之,我们的结果表明,HO-1 的表达决定了癌细胞中独特的“分子特征”,该特征富含与肿瘤发生相关的基因。HO-1 下游的蛋白质网络调节了肿瘤细胞的黏附、信号转导、运输和其他关键细胞功能,从而促进了肿瘤细胞的生长和扩散。